KU ASH 2019 Review: Current Updates in Hematologic Diseases

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

KU ASH 2019 Review: Current Updates in Hematologic Diseases

Myeloid Session
Event

ASH 2019 Update: Adding Targeted Agents to Intensive Therapy in AML Looks Promising

By KU ASH 2019 Review: Current Updates in Hematologic Diseases FEATURING Heather Male

23 views

February 13, 2020

Comments 0

Making the First Chance Count: Manuel

Feat. A. Ip

The First Treatment Choice Matters

Feat. A. Ip

Myeloid Session

ASH 2019 Update on MDS: Definitions and the Notion of Risk

KU ASH 2019 Review: Current Updates in Hematologic Diseases

M. Sekeres

19 views

ASH 2019 Update on Low-Risk MDS: Ameliorating Anemia

KU ASH 2019 Review: Current Updates in Hematologic Diseases

M. Sekeres

22 views

ASH 2019 Update on Low-Risk MDS: Tackling Thrombocytopenia / Modifyi…

KU ASH 2019 Review: Current Updates in Hematologic Diseases

M. Sekeres

21 views

ASH 2019 Update on the Higher-Risk MDS: HMA & HCT - Need to Focus on…

KU ASH 2019 Review: Current Updates in Hematologic Diseases

M. Sekeres

58 views

ASH 2019 Update: Adding Targeted Agents to Intensive Therapy in AML …

KU ASH 2019 Review: Current Updates in Hematologic Diseases

H. Male

23 views

ASH 2019 Update: Understanding the Leukemia Mutational Profile in a …

KU ASH 2019 Review: Current Updates in Hematologic Diseases

H. Male

114 views

ASH 2019 Update: CC-486 Demonstrated Improvement in OS and RFS in Ma…

KU ASH 2019 Review: Current Updates in Hematologic Diseases

H. Male

107 views

ASH 2019 Update on Myeloproliferative Neoplasms: CPI-0610 (BET Inhib…

KU ASH 2019 Review: Current Updates in Hematologic Diseases

R. Hoffman

26 views

ASH 2019 Update on the Bone Marrow Procedures with a Dry Tap: KUH Dr…

KU ASH 2019 Review: Current Updates in Hematologic Diseases

J. Woodroof

7 views

KU ASH 2019 Review: There Is a Potential Role for Allogeneic HCT Aft…

KU ASH 2019 Review: Current Updates in Hematologic Diseases

H. Abdelhakim

17 views

KU ASH 2019 Review: Retrospective Analysis of Clinical Outcomes, Tox…

KU ASH 2019 Review: Current Updates in Hematologic Diseases

J. McGuirk

169 views

KU ASH 2019 Review: CAR T-Cell Therapy is Highly Effective for R/R M…

KU ASH 2019 Review: Current Updates in Hematologic Diseases

J. McGuirk

60 views

KU ASH 2019 Review on Benign Hematology: Sutimlimab in CAD, Erythrof…

KU ASH 2019 Review: Current Updates in Hematologic Diseases

P. Harris

33 views

KU ASH 2019 Review on Benign Hematology: New FDA Approvals, 2nd-Line…

KU ASH 2019 Review: Current Updates in Hematologic Diseases

P. Harris

104 views